What is the first line therapy for demyelinating neuropathy with positive NF-155 antibodies?

Neurofascin-155 IgG antibody-associated neuropathy is a subtype of neuropathy with electrophysiologic features suggestive of demyelination, but distinctly different pathogenesis from classic CIDP, and also distinctly different response to treatments. Unlike CIDP where the target of the immune attack...